Literature DB >> 17008995

Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.

Christos S Zipitis1, Nandu Thalange.   

Abstract

Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was successfully managed with high-dose IVIG 0.5 g/kg for 4 consecutive days. No complications were noted. IVIG may be useful in the management of mycoplasma-induced SJS.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17008995     DOI： 10.1007/s00431-006-0287-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  26 in total

Review 1.  Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

Authors:  M D Kazatchkine; S V Kaveri
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

2.  Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.

Authors:  P H Halebian; V J Corder; M R Madden; J L Finklestein; G T Shires
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

3.  Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.

Authors:  J Revuz; D Penso; J C Roujeau; J C Guillaume; C R Payne; J Wechsler; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

4.  Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis.

Authors:  R Patterson; M Miller; M Kaplan; T Doan; J Brown; P Detjen; L C Grammer; P A Greenberger; M B Hogan; J Latall
Journal:  Ann Allergy       Date:  1994-07

5.  A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.

Authors:  Ercan Arca; Osman Köse; A Hakan Erbil; Mustafa Nişanci; Ahmet Akar; Ali Riza Gür
Journal:  Pediatr Dermatol       Date:  2005 Jul-Aug       Impact factor: 1.588

Review 6.  Use of intravenous immunoglobulin in children with stevens-johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature.

Authors:  Denise W Metry; Peter Jung; Moise L Levy
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

7.  Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions.

Authors:  Inge Vanfleteren; Dirk Van Gysel; Christiane De Brandt
Journal:  Pediatr Dermatol       Date:  2003 Jan-Feb       Impact factor: 1.588

Review 8.  Mycoplasma pneumoniae infections and Stevens-Johnson syndrome. Report of eight cases and review of the literature.

Authors:  M Levy; N H Shear
Journal:  Clin Pediatr (Phila)       Date:  1991-01       Impact factor: 1.168

9.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

10.  Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children.

Authors:  Payam Tristani-Firouzi; Marta J Petersen; Jeffrey R Saffle; Stephen E Morris; John J Zone
Journal:  J Am Acad Dermatol       Date:  2002-10       Impact factor: 11.527
View more
  4 in total

1.  Two cases of Stevens-Johnson syndrome following intake of klavox with review of literature.

Authors:  Kamal-Eldin Ahmed Abou-Elhamd
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

2.  Outbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome.

Authors:  Daniel Olson; Louise K Francois Watkins; Alicia Demirjian; Xia Lin; Christine C Robinson; Kristin Pretty; Alvaro J Benitez; Jonas M Winchell; Maureen H Diaz; Lisa A Miller; Teresa A Foo; Melanie D Mason; Ursula L Lauper; Oren Kupfer; Jeffrey Kennedy; Mary P Glodé; Preeta K Kutty; Samuel R Dominguez
Journal:  Pediatrics       Date:  2015-08       Impact factor: 7.124

3.  Letter to the Editor: Bilateral Subconjunctival Hemorrhage in a 3-Year-Old Girl with Mycoplasma Pneumonia.

Authors:  Tatsuya Mimura; Hidetaka Noma; Satoru Yamagami
Journal:  Open Ophthalmol J       Date:  2017-11-21

4.  Case Report and Literature Review: Clinical Characteristics of 10 Children With Mycoplasma pneumoniae-Induced Rash and Mucositis.

Authors:  Ning Chen; Miao Li
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.